These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27855998)

  • 61. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE; Wendel D; Horslen SP
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
    [No Abstract]   [Full Text] [Related]  

  • 62. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New approaches to the treatments of short bowel syndrome-associated intestinal failure.
    Jeppesen PB
    Curr Opin Gastroenterol; 2014 Mar; 30(2):182-8. PubMed ID: 24406477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Teduglutide for Safe Reduction of Parenteral Nutrient and/or Fluid Requirements in Adults: A Systematic Review.
    Naberhuis JK; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1096-1105. PubMed ID: 25883117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome.
    Mouksassi MS; Marier JF; Cyran J; Vinks AA
    Clin Pharmacol Ther; 2009 Dec; 86(6):667-71. PubMed ID: 19847163
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of enteral nutrition in adult short bowel syndrome undergoing intestinal rehabilitation: the long-term outcome.
    Gong JF; Zhu WM; Yu WK; Li N; Li JS
    Asia Pac J Clin Nutr; 2009; 18(2):155-63. PubMed ID: 19713173
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
    Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
    Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome.
    Goulet O; Dabbas-Tyan M; Talbotec C; Kapel N; Rosilio M; Souberbielle JC; Corriol O; Ricour C; Colomb V
    JPEN J Parenter Enteral Nutr; 2010; 34(5):513-20. PubMed ID: 20852179
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Growth hormone to improve short bowel syndrome intestinal autonomy: a pediatric randomized open-label clinical trial.
    Peretti N; Loras-Duclaux I; Kassai B; Restier-Miron L; Guimber D; Gottrand F; Coopman S; Michaud L; Marinier E; Yantren H; Michalski MC; Aubert F; Mercier C; Pelosse M; Lopez M; Chatelain P; Lachaux A
    JPEN J Parenter Enteral Nutr; 2011 Nov; 35(6):723-31. PubMed ID: 21975668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term outcomes of various pediatric short bowel syndrome in China.
    Zhang T; Feng H; Cao Y; Tao Y; Lu L; Yan W; Li F; Wang Y; Cai W
    Pediatr Surg Int; 2021 Apr; 37(4):495-502. PubMed ID: 33394086
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.
    Borioli V; Cereda E; Lobascio F; Mengoli C; Caraccia M; Pagani A; Aronico N; Pedrazzoli P; Di Sabatino A; Caccialanza R
    Nutrition; 2020 May; 73():110720. PubMed ID: 32088500
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
    Gondolesi GE; Pape UF; Mason JB; Allard JP; Pironi L; Casas MNV; Schwartz LK; Joly F; Gabriel A; Sabrdaran S; Zhang P; Kohl-Sobania M; Huang YW; Jeppesen PB
    Nutrients; 2024 Aug; 16(15):. PubMed ID: 39125394
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enteral Autonomy with Teduglutide Treatment of Intestinal Failure/Short Bowel Syndrome with Depleted Central Venous Access.
    Jami MM; Merritt RJ
    Dig Dis Sci; 2017 Dec; 62(12):3622-3624. PubMed ID: 28993968
    [No Abstract]   [Full Text] [Related]  

  • 74. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.
    Siu RK; Karime C; Hashash JG; Kinnucan J; Picco MF; Farraye FA
    Crohns Colitis 360; 2024 Jan; 6(1):otae007. PubMed ID: 38352117
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fat digestion using RELiZORB in children with short bowel syndrome who are dependent on parenteral nutrition: Protocol for a 90-day, phase 3, open labeled study.
    Tsikis ST; Fligor SC; Mitchell PD; Hirsch TI; Carbeau S; First E; Loring G; Rudie C; Freedman SD; Martin CR; Gura KM; Puder M
    PLoS One; 2023; 18(3):e0282248. PubMed ID: 36857339
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study.
    Daoud DC; Schwenger KJP; Jung H; Lou W; Armstrong D; Raman M; McHattie JD; Duerksen DR; Whittaker S; Bielawska B; Jurewitsch B; Gramlich L; Allard JP
    JPEN J Parenter Enteral Nutr; 2023 Sep; 47(7):878-887. PubMed ID: 37416984
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria.
    Raghu VK; Binion DG; Smith KJ
    Am J Clin Nutr; 2020 Jan; 111(1):141-148. PubMed ID: 31665212
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nutritional Issues in the Short Bowel Syndrome - Total Parenteral Nutrition, Enteral Nutrition and the Role of Transplantation.
    O'Keefe SJ
    Nestle Nutr Inst Workshop Ser; 2015; 82():75-90. PubMed ID: 26544717
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials.
    Pape UF; Iyer KR; Jeppesen PB; Kunecki M; Pironi L; Schneider SM; Seidner DL; Lee HM; Caminis J
    Therap Adv Gastroenterol; 2020; 13():1756284820905766. PubMed ID: 32341691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucagon-like peptide 2 analogues in the treatment of intestinal failure: A qualitative exploration of the views of patients and their families in decision making.
    Sowerbutts AM; Burden S; Griffiths J; Abraham A; Farrer K; Leahy G; Teubner A; Cloutier A; Twist K; Kelly S; Lal S
    Clin Nutr ESPEN; 2021 Aug; 44():263-269. PubMed ID: 34330477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.